Corcept Therapeutics Inc
CORTAs of the close on Sep 25, 2026
Price
$116.10
Market cap
$12.6B
P/E (diluted TTM)
276.4
EPS (TTM)
$0.42
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Corcept Therapeutics Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 26 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 2026-03-31 | 56,181 | $2.26M | SEC filing |
| Birchview Capital, LP | 2026-03-31 | 47,200 | $1.9M | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 18,692 | $753K | SEC filing |
| UMB Bank, n.a. | 2026-03-31 | 604 | $24.3K | SEC filing |
| MONTAG A & ASSOCIATES INC | 2026-03-31 | 542 | $21.8K | SEC filing |
| Soleus Capital Management, L.P. | 2026-03-31 | 285,531 | $11.5M | SEC filing |
| Truvestments Capital LLC | 2026-03-31 | 13 | $513 | SEC filing |
| TANG CAPITAL MANAGEMENT LLC | 2026-03-31 | 1,500,000 | $60.5M | SEC filing |
| HUNTINGTON NATIONAL BANK | 2026-03-31 | 59 | $2.38K | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 46,848 | $1.89M | SEC filing |
| ST GERMAIN D J CO INC | 2026-03-31 | 1,000 | $40.3K | SEC filing |
| Larson Financial Group LLC | 2026-03-31 | 75 | $3.02K | SEC filing |
| Mariner, LLC | 2026-03-31 | 6,006 | $242K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 13,193 | $532K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 172,078 | $6.94M | SEC filing |
| Manchester Capital Management LLC | 2026-03-31 | 17 | $686 | SEC filing |
| OPPENHEIMER & CO INC | 2026-03-31 | 16,000 | $645K | SEC filing |
| EverSource Wealth Advisors, LLC | 2026-03-31 | 340 | $13.7K | SEC filing |
| Annis Gardner Whiting Capital Advisors, LLC | 2026-03-31 | 2 | $81 | SEC filing |
- Each value is checked against Corcept Therapeutics Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- 1 row left out: the value per share it reports is far from Corcept Therapeutics Inc's share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-17 | MAHONEY DAVID L · Director | Common Stock | S — Open market or private sale | −20,000 | 84.53 | SEC filing |
| 2026-06-16 | WILSON JAMES N · Director | Common Stock | S — Open market or private sale | −4,177 | 82.69 | SEC filing |
| 2026-06-16 | WILSON JAMES N · Director | Common Stock | S — Open market or private sale | −5,823 | 83.57 | SEC filing |
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Common Stock | S — Open market or private sale | −2 | 82.45 | SEC filing |
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Common Stock | S — Open market or private sale | −9,434 | 80.02 | SEC filing |
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Common Stock | S — Open market or private sale | −11,081 | 80.94 | SEC filing |
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Common Stock | S — Open market or private sale | −19,483 | 81.81 | SEC filing |
| 2026-06-02 | Guyer William · Chief Development Officer | Common Stock | S — Open market or private sale | −20,000 | 70.60 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +40,000 | SEC filing |
| 2026-06-15 | Mokari Atabak · Chief Financial Officer | Stock option (right to buy) | M — Exercise or conversion of derivative security | −40,000 | SEC filing |
| 2026-06-02 | Guyer William · Chief Development Officer | Common Stock | M — Exercise or conversion of derivative security | +20,000 | SEC filing |
| 2026-06-02 | Guyer William · Chief Development Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −20,000 | SEC filing |
| 2026-06-02 | Robb Gary Charles · Chief Business Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −358 | SEC filing |
| 2026-06-02 | Mokari Atabak · Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −395 | SEC filing |
| 2026-06-02 | Lyon Joseph Douglas · See Remarks | Common Stock | F — Payment of exercise price or tax by delivering securities | −269 | SEC filing |
| 2026-06-02 | Maduck Sean · See Remarks | Common Stock | F — Payment of exercise price or tax by delivering securities | −452 | SEC filing |
Showing 8 of 40 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-13 | MAHONEY DAVID L · Director | Common Stock | J — Other acquisition or disposition | +24,531 | SEC filing |
| 2026-02-24 | WILSON JAMES N · Director | Common Stock | J — Other acquisition or disposition | +89,364 | SEC filing |
| 2026-01-08 | Maduck Sean · See Remarks | Common Stock | J — Other acquisition or disposition | +34,000 | SEC filing |
| 2026-01-08 | Maduck Sean · See Remarks | Common Stock | J — Other acquisition or disposition | +20,570 | SEC filing |
| 2025-12-24 | BELANOFF JOSEPH K · Chief Executive Officer | Common Stock | J — Other acquisition or disposition | +243,154 | SEC filing |
| 2025-12-12 | WILSON JAMES N · Director | Common Stock | J — Other acquisition or disposition | +200,000 | SEC filing |
| 2025-12-02 | Guyer William · Chief Development Officer | Common Stock | J — Other acquisition or disposition | +787 | SEC filing |
| 2025-11-17 (amended) | Guyer William · Chief Development Officer | Common Stock | J — Other acquisition or disposition | +5,287 | SEC filing |
Showing 8 of 8 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.